STOCK TITAN

O'Reilly (ORLY) Form 144 — 419-Share ESPP Sale via Fidelity on 08/06/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form Type: Form 144 notice for O'Reilly Automotive, Inc. (ORLY).

The filer proposes to sell 419 common shares through Fidelity Brokerage Services LLC on 08/06/2025 on NASDAQ, with an aggregate market value of $43,494.83. The filing reports 56,989,455 shares outstanding.

All listed shares were acquired via ESPP purchases between 11/30/2021 and 07/31/2024. The filing states "Nothing to Report" for securities sold during the past three months and includes the standard Rule 144 signature representation regarding material adverse information.

Positive

  • Clear compliance disclosure with broker, share count, aggregate value, sale date, and acquisition history provided
  • Small position size (419 shares, representing <0.001% of outstanding shares), suggesting limited market impact
  • All shares acquired via ESPP, indicating employee-originated holdings rather than insider awards or transfers

Negative

  • None.

Insights

TL;DR: Routine Form 144: small-position sale by an ESPP participant; immaterial to share count and likely not market-moving.

The notice discloses a proposed sale of 419 shares valued at $43,494.83, to be executed on 08/06/2025 via Fidelity on NASDAQ. Relative to the reported 56,989,455 shares outstanding, this position is <0.001% of outstanding shares, indicating negligible dilution or supply impact. All holdings were acquired through the issuer's ESPP from 11/30/2021 through 07/31/2024, consistent with employee liquidity events. The filing also reports no securities sold in the past three months.

TL;DR: Disclosure aligns with Rule 144 requirements; presents standard employee sale with customary representations.

The Form 144 provides required broker, share, and acquisition details: Fidelity Brokerage Services LLC listed as broker; acquisition method shown uniformly as ESPP Purchase. The filer affirms lack of undisclosed material adverse information per the notice. No unusual restrictions, aggregated sales, or related-party indicators are specified in the document. Given the small size and ESPP origin, this appears to be a routine compliance filing rather than a governance red flag.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ORLY Form 144 disclose?

The filing discloses a proposed sale of 419 common shares via Fidelity on 08/06/2025 with an aggregate market value of $43,494.83 on NASDAQ.

How many ORLY shares are outstanding per the filing?

The filing reports 56,989,455 shares outstanding.

What acquisition method is listed for the shares to be sold?

All listed shares were acquired through the issuer's ESPP (Employee Stock Purchase Plan) between 11/30/2021 and 07/31/2024.

Were any ORLY securities sold by the filer in the past 3 months?

The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed sale?

The broker named is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

Does the filing indicate undisclosed material information?

By signing, the filer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.